Alissa Coram and Ken Shreve walk through Thursday’s market action with key stocks to watch in Stock Market Today.<br><br>Hosted by Simplecast, an AdsWizz company. See pcm.adswizz.com for information about our collection and use of personal data for advertising.

Nasdaq Breaks Support As Chip Sell-Off Deepens; Knight-Swift, Canadian Pacific, AbbVie In Focus

Stock Market Today With IBD

Good afternoon, everyone, and welcome to Stock Market Today for July 16th. It's Alissa Coram along with Ken Shreve here. We've got a look at the action in today's session. Seeing a lot of red out there, Ken, with a lot of the weakness once again focused in the tech sector.

Yes, indeed, Alissa. It's not often when you look at the Nasdaq 100 and you're seeing Keurig, Dr. Pepper, and Old Dominion Freightline, and Syntas, the uniform maker, leading the Nasdaq 100. But that's what we're looking at today, these technology stocks not leading the Nasdaq 100 these days. But yeah, lots of selling in the Nasdaq 100 today, chip stocks under a lot of pressure.

So, but we did find three stocks to look at. We're going to take a look at a drug maker AbbVie. We had great earnings from J.B. Hunt Transport, but we're going to take a look at another trucking stock. That's going to be KNX. And then we're also going to take a look at a railroad stock because railroad stocks, a lot of them hit new highs today.

Transport's performed well overall. So that's going to be CP is the ticker. All right. We'll take a look at those stocks. But first, let's take a closer look at the major indexes. So the weakness in tech definitely showing up in the Nasdaq composite with the tech heavy index down one and a half percent on the day. You mentioned the Nasdaq 100 and definitely a fun fact there about what was leading that today.

Nasdaq Breaks Support As Chip Sell-Off Deepens; Knight-Swift, Canadian Pacific, AbbVie In Focus

Read the full transcript

The candid version is on a podcast,
not the earnings call.

Nasdaq Breaks Support As Chip Sell-Off Deepens; Knight-Swift, Canadian Pacific, AbbVie In Focus

Read the full transcript

The candid version is on a podcast, not the earnings call.

The candid version is on a podcast,
not the earnings call.